Sangui Biotech International Inc (SGBI) financial statements (2021 and earlier)

Company profile

Business Address 352 SOUTH 200 WEST
FARMINGTON, UT 84025
State of Incorp. CO
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9152721577018
Cash and cash equivalents9152721577018
Receivables151735 12817
Prepaid expense141392134 
Other undisclosed current assets23760212838
Total current assets:4149791029411072
Noncurrent Assets
Property, plant and equipment22     
Deferred costs      50
Other undisclosed noncurrent assets7975     
Total noncurrent assets:8177    50
TOTAL ASSETS:1211257910294110122
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:      143
Other undisclosed accounts payable and accrued liabilities      143
Debt740619478    
Due to related parties554228    
Other undisclosed current liabilities146131164453354 319
Total current liabilities:940791671453354 462
Noncurrent Liabilities
Long-term debt and lease obligation6364     
Operating lease, liability6364
Other undisclosed noncurrent liabilities(63)(64)     
Total noncurrent liabilities:6364     
Total liabilities:1,003855671453354 462
Stockholders' equity
Stockholders' equity attributable to parent, including:(233)(83)49(351)(261)(248)(340)
Common stock33,02833,02832,96732,86432,71032,39331,933
Treasury stock, value(19)(19)(19)191919339
Additional paid in capital4,5134,5134,5134,5134,5134,5134,621
Accumulated other comprehensive income91929193 123170
Accumulated deficit(37,845)(37,696)(37,504)(37,180)(36,978)(36,669)(36,161)
Other undisclosed stockholders' equity attributable to parent   (661)(525)(626)(1,242)
Stockholders' equity attributable to noncontrolling interest(649)(647)(641)    
Total stockholders' equity:(882)(730)(592)(351)(261)(248)(340)
Other undisclosed liabilities and equity     358 
TOTAL LIABILITIES AND EQUITY:1211257910294110122

Income statement (P&L) ($ in thousands)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Revenues482988776848127
Cost of revenue
(Cost of Goods and Services Sold)
   (0)(1)(0)(1)
Gross profit:482988776748127
Operating expenses(219)(210)(426)(285)(384)(409)(879)
Other operating expense, net     (85) 
Operating loss:(172)(181)(338)(208)(317)(446)(752)
Nonoperating income (expense)(79)(17)(5) 3(28)(6)
Investment income, nonoperating     (28) 
Foreign currency transaction gain (loss), before tax(63)47 3  
Other nonoperating expense      (6)
Interest and debt expense(16)(14)(12)89706
Loss from continuing operations before equity method investments, income taxes:(267)(213)(354)(200)(304)(405)(752)
Other undisclosed loss from continuing operations before income taxes   (16)(25)(42)(6)
Loss before gain (loss) on sale of properties:(267)(213)(354)(216)(330)(446)(758)
Other undisclosed net income161412    
Net loss:(251)(199)(343)(216)(330)(446)(758)
Net income attributable to noncontrolling interest      54
Other undisclosed net income (loss) attributable to parent6619(29)   
Net loss attributable to parent:(245)(193)(324)(245)(330)(446)(705)
Other undisclosed net income available to common stockholders, basic     24 
Net loss available to common stockholders, diluted:(245)(193)(324)(245)(330)(422)(705)

Comprehensive Income ($ in thousands)

12/31/2020
TTM
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
Net loss:(251)(199)(343)(216)(330)(446)(758)
Other comprehensive income (loss)252198344   (719)
Comprehensive income (loss):1(0)1(216)(330)(446)(1,477)
Comprehensive income, net of tax, attributable to noncontrolling interest      54
Other undisclosed comprehensive loss, net of tax, attributable to parent     (47) 
Comprehensive income (loss), net of tax, attributable to parent:1(0)1(216)(330)(493)(1,424)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: